Vitiligo Patients Often Exhibit Abnormal Ocular Findings

This article originally appeared here.
Share this content:
Vitiligo Patients Often Exhibit Abnormal Ocular Findings
Vitiligo Patients Often Exhibit Abnormal Ocular Findings

MONDAY, Feb. 29, 2016 (HealthDay News) -- Patients with vitiligo have significant differences in terms of Schirmer test results, lens, and fundus findings, versus controls without systemic disease, according to a study published in the March issue of the International Journal of Dermatology.

Remzi Karadag, M.D., from the Istanbul Medeniyet University, and colleagues examined ocular manifestations in patients with vitiligo. Data were included for 61 patients with vitiligo and 57 controls, without any systemic disease. The authors conducted otorefractometry, keratometry, visual acuity test, intraocular pressure measurement, anterior segment, and fundus examination of the eye with slit lamp, Schirmer test, and perimetry.

The researchers found that the mean Schirmer test results for patients were 16.74 ± 9.11 mm and 17.64 ± 9.41 mm for the right and left eye, respectively, compared with 21.96 ± 12.51 mm and 23.42 ± 12.51 mm for the right and left eye of controls, respectively. Thirty-six eyes from patients and 12 control eyes showed lenticular findings. Some fundus findings were seen in 29 eyes in the vitiligo group and four control eyes. Schirmer test results, lens, and fundus findings differed significantly between the groups (all P < 0.05). There were no significant differences in age, gender, visual acuity, refraction, keratometry, intraocular pressure, perimetry, and corneal findings (all P > 0.05).

"Patients with vitiligo may have more lenticular and retinal findings than normal," the authors write. "They can be more prone to dry eye syndrome as well."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plan to Relax Coal-Fired Power Plant Rules Could Up Mortality

Plan to Relax Coal-Fired Power Plant Rules Could ...

EPA predicts between 470 and 1,400 premature deaths a year by 2030

FDA Extends EpiPen Expiration Dates to Tackle Shortage

FDA Extends EpiPen Expiration Dates to Tackle Shortage

Shortages due to factors such as supply disruptions and manufacturer issues

USPSTF Updates Guidance for Cervical Cancer Screening

USPSTF Updates Guidance for Cervical Cancer Screening

Cytology recommended every three years from age 21; different screening options from age 30 to 65

is free, fast, and customized just for you!




Already a member?

Sign In Now »